Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Schepisi

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|July 13, 2023
Immunogenomic profiles associated with response to life-prolonging agents in prostate cancerVincenza Conteduca, Nicole Brighi, Giuseppe Schepisi, et al.
Oncology Reviews|July 30, 2016
Impact of Non-Pulmonary Visceral Metastases in the Prognosis and Practice of Metastatic Testicular Germ Cell TumorsLorena Rossi, Filippo Martignano, Valentina Gallà, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2016
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinomaAlberto Farolfi, Giuseppe Schepisi, Vincenza Conteduca, et al.
International Journal of Molecular Sciences|December 9, 2023
Biomarkers for Salvage Therapy in Testicular Germ Cell TumorsMilena Urbini, Sara Bleve, Giuseppe Schepisi, et al.
Medicine|December 30, 2018
Vitiligo-like lesions in a patient treated with nivolumab for renal cell carcinomaCristian Lolli, Matelda Medri, Michela Ricci, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2017
Urinary RNA-based biomarkers for prostate cancer detectionFilippo Martignano, Lorena Rossi, Antonio Maugeri, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 15, 2016
Urothelial Cancer: Inflammatory Mediators and Implications for ImmunotherapyGiuseppe Schepisi, Matteo Santoni, Francesco Massari, et al.
Cancers|October 23, 2021
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical ImplicationsMilena Urbini, Giuseppe Schepisi, Sara Bleve, et al.
Critical Reviews in Oncology/Hematology|July 11, 2020
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinomaCristian Lolli, Amelia Altavilla, Vincenza Conteduca, et al.
Critical Reviews in Oncology/Hematology|December 14, 2020
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectivesNicole Brighi, Vincenza Conteduca, Cristian Lolli, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|July 13, 2023
Immunogenomic profiles associated with response to life-prolonging agents in prostate cancerVincenza Conteduca, Nicole Brighi, Giuseppe Schepisi, et al.
Oncology Reviews|July 30, 2016
Impact of Non-Pulmonary Visceral Metastases in the Prognosis and Practice of Metastatic Testicular Germ Cell TumorsLorena Rossi, Filippo Martignano, Valentina Gallà, et al.
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2016
Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinomaAlberto Farolfi, Giuseppe Schepisi, Vincenza Conteduca, et al.
International Journal of Molecular Sciences|December 9, 2023
Biomarkers for Salvage Therapy in Testicular Germ Cell TumorsMilena Urbini, Sara Bleve, Giuseppe Schepisi, et al.
Medicine|December 30, 2018
Vitiligo-like lesions in a patient treated with nivolumab for renal cell carcinomaCristian Lolli, Matelda Medri, Michela Ricci, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2017
Urinary RNA-based biomarkers for prostate cancer detectionFilippo Martignano, Lorena Rossi, Antonio Maugeri, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 15, 2016
Urothelial Cancer: Inflammatory Mediators and Implications for ImmunotherapyGiuseppe Schepisi, Matteo Santoni, Francesco Massari, et al.
Cancers|October 23, 2021
Primary Mediastinal and Testicular Germ Cell Tumors in Adolescents and Adults: A Comparison of Genomic Alterations and Clinical ImplicationsMilena Urbini, Giuseppe Schepisi, Sara Bleve, et al.
Critical Reviews in Oncology/Hematology|July 11, 2020
A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinomaCristian Lolli, Amelia Altavilla, Vincenza Conteduca, et al.
Critical Reviews in Oncology/Hematology|December 14, 2020
The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectivesNicole Brighi, Vincenza Conteduca, Cristian Lolli, et al.
Pageof 7